can glp 1 affect kidneys GLP-1 agonists in the treatment of chronic kidney disease in type 2 diabetes and obesity Kidney Outcomes With Glucagon-Like Peptide-1

Description

Think about building small but powerful meals: Protein +

patent describes new glucagon-like peptide 1 receptor (GLP-1R) agonists reported to be useful for the treatment of diabetes type 2, hyperglycemia and obesity.

They work by suppressing hunger and cravings, keeping you full longer, and by enhancing natural mechanisms in the body to reduce inflammatory insulin resistance

A retrospective analysis of more than 110,000 women between the ages of 45 and 80 found that those who take GLP-1 medications are about 30% less likely to develop breast cancer than those who do not take GLP-1 medications.